Gliclazide, sold under the brand name Diamicron among others, is a sulfonylurea type of anti-diabetic medication, used to treat type 2 diabetes. It is used when dietary changes, exercise, and weight loss are not enough. It is taken by mouth.
Side effect may include low blood sugar, vomiting, abdominal pain, rash, and liver problems. Use by those with significant kidney problems or liver problems or who are pregnant is not recommended. Gliclazide is in the sulfonylurea family of medications. It works mostly by increasing the release of insulin.
Gliclazide was patented in 1966 and approved for medical use in 1972. It is on the World Health Organization's List of Essential Medicines. It is not available for sale in the United States.
|
Read full article at Wikipedia
|
InChI=1S/C12H9NO/c1-3-7-11-9(5-1)13-10-6-2-4-8-12(10)14-11/h1-8,13H |
TZMSYXZUNZXBOL-UHFFFAOYSA-N |
N1C2=CC=CC=C2OC2=CC=CC=C12 |
|
radical scavenger
A role played by a substance that can react readily with, and thereby eliminate, radicals.
|
|
ferroptosis inhibitor
Any substance that inhibits the process of ferroptosis (a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides) in organisms.
|
|
View more via ChEBI Ontology
phenazoxine
|
ChemIDplus
|
phenoxazine
|
ChemIDplus
|
135-67-1
|
CAS Registry Number
|
NIST Chemistry WebBook
|
135-67-1
|
CAS Registry Number
|
ChemIDplus
|
143234
|
Reaxys Registry Number
|
Reaxys
|
17236778
|
PubMed citation
|
Europe PMC
|
21139335
|
PubMed citation
|
Europe PMC
|
25584392
|
PubMed citation
|
Europe PMC
|
28885854
|
PubMed citation
|
Europe PMC
|
29675187
|
PubMed citation
|
Europe PMC
|
31210382
|
PubMed citation
|
Europe PMC
|
32907323
|
PubMed citation
|
Europe PMC
|
33156606
|
PubMed citation
|
Europe PMC
|
33629835
|
PubMed citation
|
Europe PMC
|
|